The Greenrose Holding Company Inc. The Greenrose Holding Company Inc. (GNRSU) operates as a cultivator, processor, and seller of medical cannabis products through its subsidiaries in the United States. The company produces and packages medical cannabis flower and derivative products including concentrates, edibles, and other cannabinoid-based items; it focuses on high-quality flower derived from unique genetics and scalable cultivation methods primarily in Connecticut and Arizona. Founded in 2014 and headquartered in Amityville, New York, Greenrose targets medical cannabis markets with vertically integrated operations that emphasize cultivation capacity ramp-up and horizontal consolidation. In June 2024, the company filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of New York, marking a significant operational wind-down; prior to this, it completed a business combination with Theraplant, LLC in November 2021, secured a $105 million senior secured credit facility from DXR Finance, LLC, and pursued acquisitions of Shango Holdings, Inc., Futureworks LLC, and assets from True Harvest, LLC.